The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for JR Jackson


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography.EBI
University of Pennsylvania
Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties.EBI
Glaxosmithkline
Antitumor activity of an allosteric inhibitor of centromere-associated protein-E.EBI
Cytokinetics Inc
Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis.EBI
GlaxoSmithKline Pharmaceuticals
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin.EBI
GlaxoSmithKline
Novel ATP-competitive kinesin spindle protein inhibitors.EBI
Glaxosmithkline
Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.EBI
University of Pennsylvania
Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's diseaseBDB
University of Kansas
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITYBDB
Ifm Due